Clinical trials
Phase 1/2 Multiple Myeloma trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 11 |
| Active, not recruiting | 10 |
| Terminated | 9 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 6 |
| GlaxoSmithKline | 6 |
| Hoffmann-La Roche | 4 |
| PETHEMA Foundation | 3 |
| Regeneron Pharmaceuticals | 3 |
| Bayer | 2 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2 |
| Teva Branded Pharmaceutical Products R&D LLC | 2 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 46 |
| Recurrence | 10 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Hematologic Neoplasms | 2 |
| Myelodysplastic Syndromes | 2 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Glioblastoma | 1 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.